• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种综合的功能基因组学方法鉴定了由脊索瘤中的 brachyury(T)所调控的调控网络。

An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.

机构信息

Randall Division of Cell and Molecular Biophysics, New Hunt's House, King's College London, Guy's Campus, London, SE1 1UL, UK.

出版信息

J Pathol. 2012 Nov;228(3):274-85. doi: 10.1002/path.4082. Epub 2012 Sep 26.

DOI:10.1002/path.4082
PMID:22847733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6089345/
Abstract

Chordoma is a rare malignant tumour of bone, the molecular marker of which is the expression of the transcription factor, brachyury. Having recently demonstrated that silencing brachyury induces growth arrest in a chordoma cell line, we now seek to identify its downstream target genes. Here we use an integrated functional genomics approach involving shRNA-mediated brachyury knockdown, gene expression microarray, ChIP-seq experiments, and bioinformatics analysis to achieve this goal. We confirm that the T-box binding motif of human brachyury is identical to that found in mouse, Xenopus, and zebrafish development, and that brachyury acts primarily as an activator of transcription. Using human chordoma samples for validation purposes, we show that brachyury binds 99 direct targets and indirectly influences the expression of 64 other genes, thereby acting as a master regulator of an elaborate oncogenic transcriptional network encompassing diverse signalling pathways including components of the cell cycle, and extracellular matrix components. Given the wide repertoire of its active binding and the relative specific localization of brachyury to the tumour cells, we propose that an RNA interference-based gene therapy approach is a plausible therapeutic avenue worthy of investigation.

摘要

软骨肉瘤是一种罕见的骨恶性肿瘤,其分子标志物是转录因子 brachyury 的表达。我们最近证明,沉默 brachyury 会诱导软骨肉瘤细胞系生长停滞,现在我们试图确定其下游靶基因。在这里,我们使用了一种整合的功能基因组学方法,包括 shRNA 介导的 brachyury 敲低、基因表达微阵列、ChIP-seq 实验和生物信息学分析来实现这一目标。我们证实,人类 brachyury 的 T 盒结合基序与在小鼠、非洲爪蟾和斑马鱼发育中发现的基序相同,并且 brachyury 主要作为转录激活剂发挥作用。使用人软骨肉瘤样本进行验证,我们表明 brachyury 结合 99 个直接靶标,并间接地影响 64 个其他基因的表达,从而作为一个复杂致癌转录网络的主调控因子,该网络包括细胞周期的组成部分和细胞外基质成分等多种信号通路。鉴于其活性结合的广泛谱和 brachyury 相对特异性地定位于肿瘤细胞,我们提出基于 RNA 干扰的基因治疗方法是一种值得研究的合理治疗途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe2/6089345/7c7b14e604ef/emss-78919-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe2/6089345/bed53236d826/emss-78919-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe2/6089345/6d1237511b69/emss-78919-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe2/6089345/36aa477616bb/emss-78919-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe2/6089345/dd64311a8753/emss-78919-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe2/6089345/7c7b14e604ef/emss-78919-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe2/6089345/bed53236d826/emss-78919-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe2/6089345/6d1237511b69/emss-78919-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe2/6089345/36aa477616bb/emss-78919-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe2/6089345/dd64311a8753/emss-78919-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe2/6089345/7c7b14e604ef/emss-78919-f005.jpg

相似文献

1
An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.一种综合的功能基因组学方法鉴定了由脊索瘤中的 brachyury(T)所调控的调控网络。
J Pathol. 2012 Nov;228(3):274-85. doi: 10.1002/path.4082. Epub 2012 Sep 26.
2
'The chicken or the egg?' dilemma strikes back for the controlling mechanism in chordoma(#).“先有鸡还是先有蛋”的困境再次困扰着脊索瘤 (#) 的控制机制。
J Pathol. 2012 Nov;228(3):261-5. doi: 10.1002/path.4102.
3
Brachyury and chordoma: the chondroid-chordoid dilemma resolved?短尾蛋白与脊索瘤:软骨样-脊索样难题得到解决了吗?
J Pathol. 2006 Jun;209(2):143-6. doi: 10.1002/path.1987.
4
Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target.生成软骨肉瘤细胞系 JHC7 及鉴定 Brachyury 为一个新的分子靶点。
J Neurosurg. 2011 Oct;115(4):760-9. doi: 10.3171/2011.5.JNS11185. Epub 2011 Jun 24.
5
Cucurbitacin B Exhibits Antitumor Effects on Chordoma Cells via Disruption of Brachyury.葫芦素B通过破坏短尾相关蛋白对脊索瘤细胞发挥抗肿瘤作用。
Int J Mol Sci. 2025 Apr 18;26(8):3864. doi: 10.3390/ijms26083864.
6
From notochord formation to hereditary chordoma: the many roles of Brachyury.从脊索形成到遗传性脊索瘤:Brachyury 的多种作用。
Biomed Res Int. 2013;2013:826435. doi: 10.1155/2013/826435. Epub 2013 Mar 31.
7
Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma.Brachyury 基因拷贝数增加和 PI3K/Akt 通路的激活:与颅底脊索瘤中致癌性 Brachyury 表达的上调相关。
J Neurosurg. 2018 May;128(5):1428-1437. doi: 10.3171/2016.12.JNS161444. Epub 2017 Jul 28.
8
Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death.组蛋白 H3K27 去甲基酶抑制可使 Brachyury(TBXT)失活并促进脊索瘤细胞死亡。
Cancer Res. 2020 Oct 15;80(20):4540-4551. doi: 10.1158/0008-5472.CAN-20-1387. Epub 2020 Aug 27.
9
The driver landscape of sporadic chordoma.散发性脊索瘤的驱动因素格局
Nat Commun. 2017 Oct 12;8(1):890. doi: 10.1038/s41467-017-01026-0.
10
Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity.靶向 brachyury 降解破坏了高度特异性的自动调节程序,该程序控制脊索瘤细胞的特性。
Cell Rep Med. 2021 Jan 19;2(1):100188. doi: 10.1016/j.xcrm.2020.100188.

引用本文的文献

1
The TBXT rs2305089 SNP links the benign notochordal cell tumour and chordoma.TBXT基因的rs2305089单核苷酸多态性与良性脊索细胞瘤和脊索瘤相关。
J Pathol. 2025 Jul;266(3):247-257. doi: 10.1002/path.6427. Epub 2025 May 5.
2
Single-cell Transcriptomic Studies Unveil Potential Nodes of the Notochord Gene Regulatory Network.单细胞转录组研究揭示了脊索基因调控网络的潜在节点。
Integr Comp Biol. 2024 Nov 21;64(5):1194-1213. doi: 10.1093/icb/icae084.
3
Chordoma cells possess bone-dissolving activity at the bone invasion front.脊索瘤细胞在骨侵袭前沿具有溶骨性活性。

本文引用的文献

1
Frequent activation of EGFR in advanced chordomas.在晚期脊索瘤中表皮生长因子受体(EGFR)的频繁激活。
Clin Sarcoma Res. 2011 Jul 25;1(1):4. doi: 10.1186/2045-3329-1-4.
2
Genomic targets of Brachyury (T) in differentiating mouse embryonic stem cells.Brachyury(T)在分化中的小鼠胚胎干细胞中的基因组靶标。
PLoS One. 2012;7(3):e33346. doi: 10.1371/journal.pone.0033346. Epub 2012 Mar 30.
3
Phase II study of imatinib in advanced chordoma.伊马替尼治疗晚期脊索瘤的 II 期研究。
Cell Oncol (Dordr). 2024 Oct;47(5):1663-1677. doi: 10.1007/s13402-024-00946-6. Epub 2024 Apr 23.
4
Cis-regulatory interfaces reveal the molecular mechanisms underlying the notochord gene regulatory network of Ciona.顺式调控界面揭示了海鞘脊索基因调控网络的分子机制。
Nat Commun. 2024 Apr 8;15(1):3025. doi: 10.1038/s41467-024-46850-3.
5
Multimodal profiling of chordoma immunity reveals distinct immune contextures.脊索瘤免疫的多模态分析揭示了不同的免疫背景。
J Immunother Cancer. 2024 Jan 25;12(1):e008138. doi: 10.1136/jitc-2023-008138.
6
Conserved enhancers control notochord expression of vertebrate Brachyury.保守增强子控制脊椎动物 Brachyury 的脊索表达。
Nat Commun. 2023 Oct 18;14(1):6594. doi: 10.1038/s41467-023-42151-3.
7
Virus-like particle-based delivery of Cas9/guide RNA ribonucleoprotein efficiently edits the brachyury gene and inhibits chordoma growth in vivo.基于病毒样颗粒递送Cas9/向导RNA核糖核蛋白可有效编辑短尾相关转录因子基因并在体内抑制脊索瘤生长。
Discov Oncol. 2023 May 18;14(1):70. doi: 10.1007/s12672-023-00680-9.
8
Next-generation plasmids for transgenesis in zebrafish and beyond.用于斑马鱼及其它动物基因转移的新一代质粒。
Development. 2023 Apr 15;150(8). doi: 10.1242/dev.201531. Epub 2023 Apr 19.
9
Emerging target discovery and drug repurposing opportunities in chordoma.脊索瘤中新兴的靶点发现与药物重新利用机会
Front Oncol. 2022 Oct 27;12:1009193. doi: 10.3389/fonc.2022.1009193. eCollection 2022.
10
A correlation analysis of sacrococcygeal chordoma imaging and clinical characteristics with the prognostic factors.骶尾部脊索瘤影像学及临床特征与预后因素的相关性分析
Front Oncol. 2022 Sep 26;12:1012918. doi: 10.3389/fonc.2022.1012918. eCollection 2022.
J Clin Oncol. 2012 Mar 20;30(9):914-20. doi: 10.1200/JCO.2011.35.3656. Epub 2012 Feb 13.
4
The challenge of choosing appropriate end points in single-arm phase II studies of rare diseases.在罕见病单臂II期研究中选择合适终点的挑战。
J Clin Oncol. 2012 Mar 20;30(9):896-8. doi: 10.1200/JCO.2011.40.6942. Epub 2012 Feb 13.
5
Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers.醛酮还原酶1B10及其在耐药性癌症增殖能力中的作用。
Front Pharmacol. 2012 Jan 31;3:5. doi: 10.3389/fphar.2012.00005. eCollection 2012.
6
An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma.遗传性和散发性 2 型乳头状肾细胞癌之间存在抗氧化反应表型。
Cancer Cell. 2011 Oct 18;20(4):511-23. doi: 10.1016/j.ccr.2011.08.024.
7
Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review.表皮生长因子受体靶向治疗晚期脊索瘤的疗效:病例报告及文献复习。
BMC Cancer. 2011 Oct 4;11:423. doi: 10.1186/1471-2407-11-423.
8
Incidence and survival of malignant bone sarcomas in England 1979-2007.1979-2007 年英格兰恶性骨肉瘤的发病率和存活率。
Int J Cancer. 2012 Aug 15;131(4):E508-17. doi: 10.1002/ijc.26426. Epub 2011 Nov 2.
9
Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target.生成软骨肉瘤细胞系 JHC7 及鉴定 Brachyury 为一个新的分子靶点。
J Neurosurg. 2011 Oct;115(4):760-9. doi: 10.3171/2011.5.JNS11185. Epub 2011 Jun 24.
10
IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells.白细胞介素-8 信号通路在人类癌细胞的上皮间质转化中发挥着关键作用。
Cancer Res. 2011 Aug 1;71(15):5296-306. doi: 10.1158/0008-5472.CAN-11-0156. Epub 2011 Jun 8.